Generic Name and Formulations:
Malathion 0.5%; lotion; contains alcohol 78%.
Indications for OVIDE:
Adults and Children:
<6yrs: not established. ≥6yrs: apply to dry hair until hair and scalp are thoroughly wet. Let hair dry naturally (do not use blow dryer or other heat source). Shampoo and rinse after 8–12hrs; remove dead lice and eggs with nit comb. May repeat once after 7–9 days. Wash hands after application. Wash or dryclean bedding or clothing appropriately.
For use on scalp only. Remove if irritation occurs, may reapply if irritation subsides; discontinue if irritation recurs. Avoid eyes. Product is flammable; keep away from heat and flame (including smoking, hair dryers, electric curlers). Pregnancy (Cat.B). Nursing mothers.
Stinging, irritation, chemical burns.
Sign Up for Free e-newsletters
- Adhering to Cytoreductive Therapy Use May Improve Outcomes in Polycythemia Vera
- FDA, EU Approvals Sought for Split Dose Regimen of Daratumumab for Multiple Myeloma
- Alternate Dosing of Ruxolitinib May Alleviate Anemia in Myelofibrosis
- Hope, Gratitude, and Spirituality: What They Mean to Cancer Patients
- Combined Digital Screening Best for Detecting Breast Cancers
- NCCIH HerbList App Launched to Provide Information on Herbal Products
- Seeking Reliable Information on Herbal Products
- Metformin Use May Improve Survival Outcomes in Bladder Cancer
- Higher Vitamin D Levels Associated With Lower Breast Cancer Risk
- Nurse-Led Program Improves Health, Financial Outcomes in Outpatient Chemotherapy
- Oral Hydration Effectively Reduced Risk of Nephrotoxity After Cisplatin
- Young Survivors of Breast Cancer Report Sexual Quality of Life Declines After Treatment
- The Efficacy and Tolerance of High Pressure Oxygen Combined With Chemotherapy in Postoperative Patients With Advanced Gastric Cancer
- Hepatocellular Cancer Pain: Impact and Management Challenges
- Serum Albumin May Indicate Prognosis for Survival in Acute Myeloblastic Leukemia
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|